ArticleClinical and translational science2022
Evaluation of atezolizumab immunogenicity: Efficacy and safety (Part 2).
Solange Peters et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this paperpooled ittrialcites it